Back to Trades
Dai Junyi
Chief Executive OfficerCIK 0002022463
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Dai Junyi, Chief Executive Officer, has disclosed $0 in transactions — all concentrated in Indaptus Therapeutics, Inc. (INDP). Data is sourced from official SEC Form 3, 4, and 5 filings.